Skip to content

The value of rubiprostone in bowel preparation for colonoscopy

The value of rubiprostone in bowel preparation for colonoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117661
Enrollment
Unknown
Registered
2026-01-27
Start date
2025-03-18
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Group A:If patients were enrolled in group A, they did not receive rubiprostone. On the day before the examination (breakfast, lunch and dinner), dietary restriction was carried out, only low-residue
Group B:If the patients were enrolled in group B, they were required to eat a low-residue diet from the day before the examination (breakfast, lunch, and dinner), take 1 rubiprostone soft capsule at 1
Group C:If the patients were enrolled in the C group, they were required to eat a low-residue diet from the day before the examination (breakfast, lunch, and dinner), take 1 rubiprostone soft capsule

Sponsors

Ningbo Medical Centre Lihuili Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.18-75 years old, male or female; 2. Planned to undergo diagnostic, screening, or surveillance colonoscopy; 3. Written informed consent was obtained;

Exclusion criteria

Exclusion criteria: 1.severe cardiac, cerebral, pulmonary, or renal complications or acute myocardial infarction within 6 months; 2.Pregnant and lactating women; 3.Stool Bristol score of 7 (watery, no solid mass), considered diarrhea; 4.Had participated in other interventional clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
Boston score for bowel preparation;

Secondary

MeasureTime frame
Adverse reactions of bowel preparation;Time to complete bowel preparation;Tolerability of laxatives;

Countries

China

Contacts

Public ContactFeng Xu

Ningbo Medical Centre Lihuili Hospital

xufengxh19@163.com+86 13857882079

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026